Template:Amphetamine base in marketed amphetamine medications

From HandWiki
Amphetamine base in marketed amphetamine medications
drug formula molecular mass
[note 1]
amphetamine base
[note 2]
amphetamine base
in equal doses
doses with
equal base
content
[note 3]
(g/mol) (percent) (30 mg dose)
total base total dextro- levo- dextro- levo-
dextroamphetamine sulfate[2][3] (C9H13N)2•H2SO4
368.49
270.41
73.38%
73.38%
22.0 mg
30.0 mg
amphetamine sulfate[4] (C9H13N)2•H2SO4
368.49
270.41
73.38%
36.69%
36.69%
11.0 mg
11.0 mg
30.0 mg
Adderall
62.57%
47.49%
15.08%
14.2 mg
4.5 mg
35.2 mg
25% dextroamphetamine sulfate[2][3] (C9H13N)2•H2SO4
368.49
270.41
73.38%
73.38%
25% amphetamine sulfate[4] (C9H13N)2•H2SO4
368.49
270.41
73.38%
36.69%
36.69%
25% dextroamphetamine saccharate[5] (C9H13N)2•C6H10O8
480.55
270.41
56.27%
56.27%
25% amphetamine aspartate monohydrate[6] (C9H13N)•C4H7NO4•H2O
286.32
135.21
47.22%
23.61%
23.61%
lisdexamfetamine dimesylate[7] C15H25N3O•(CH4O3S)2
455.49
135.21
29.68%
29.68%
8.9 mg
74.2 mg
amphetamine base suspension[note 4][8] C9H13N
135.21
135.21
100%
76.19%
23.81%
22.9 mg
7.1 mg
22.0 mg

References

  1. "Molecular Weight Calculator". Lenntech. http://www.lenntech.com/calculators/molecular/molecular-weight-calculator.htm. Retrieved 19 August 2015. 
  2. 2.0 2.1 "Dextroamphetamine Sulfate USP". Mallinckrodt Pharmaceuticals. March 2014. http://www2.mallinckrodt.com/WorkArea/DownloadAsset.aspx?id=2147491568. Retrieved 19 August 2015. 
  3. 3.0 3.1 "D-amphetamine sulfate". Tocris. 2015. http://www.tocris.com/dispprod.php?ItemId=5305#.VXpspvlViko. Retrieved 19 August 2015. 
  4. 4.0 4.1 "Amphetamine Sulfate USP". Mallinckrodt Pharmaceuticals. March 2014. http://www2.mallinckrodt.com/WorkArea/DownloadAsset.aspx?id=2147491599. Retrieved 19 August 2015. 
  5. "Dextroamphetamine Saccharate". Mallinckrodt Pharmaceuticals. March 2014. http://www2.mallinckrodt.com/WorkArea/DownloadAsset.aspx?id=2147491576. Retrieved 19 August 2015. 
  6. "Amphetamine Aspartate". Mallinckrodt Pharmaceuticals. March 2014. http://www2.mallinckrodt.com/WorkArea/DownloadAsset.aspx?id=2147491591. Retrieved 19 August 2015. 
  7. "Vyvanse Prescribing Information". Shire US Inc.. May 2017. pp. 17–21. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021977s045,208510s001lbl.pdf. Retrieved 10 July 2017. 
  8. 8.0 8.1 8.2 8.3 "Dyanavel XR Prescribing Information". United States Food and Drug Administration. Tris Pharma, Inc.. May 2017. pp. 1–14. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208147s003lbl.pdf. Retrieved 4 August 2017. "DYANAVEL XR contains d-amphetamine and l-amphetamine in a ratio of 3.2 to 1 ...
    DOSAGE FORMS AND STRENGTHS
    Extended-release oral suspension contains 2.5 mg amphetamine base per mL."
     
  1. For uniformity, molecular masses were calculated using the Lenntech Molecular Weight Calculator[1] and were within 0.01g/mol of published pharmaceutical values.
  2. Amphetamine base percentage = molecular massbase / molecular masstotal. Amphetamine base percentage for Adderall = sum of component percentages / 4.
  3. dose = (1 / amphetamine base percentage) × scaling factor = (molecular masstotal / molecular massbase) × scaling factor. The values in this column were scaled to a 30 mg dose of dextroamphetamine sulfate. Due to pharmacological differences between these medications (e.g., differences in the release, absorption, conversion, concentration, differing effects of enantiomers, half-life, etc.), the listed values should not be considered equipotent doses.
  4. This product (Dyanavel XR) is an oral suspension (i.e., a drug that is suspended in a liquid and taken by mouth) that contains 2.5 mg/mL of amphetamine base.[8] The amphetamine base contains dextro- to levo-amphetamine in a ratio of 3.2:1,[8] which is approximately the ratio in Adderall. The product uses an ion exchange resin to achieve extended release of the amphetamine base.[8]